We evaluated the high therapeutic effect of ECCNBs by the uptake behavior of SGC-7901 cells.
The authors evaluated the high sensitivity (detection limit of 10 ng/mL) and no cross-reactions of this developed tool, confirming its feasible use for the rapid detection and surveillance of toxigenic V. cholerae that is a public health threat.
We evaluated the high risk group (defined as AML and ALL in CR2/3, CML in CP2 or AP, and MDS RAEB or RAEBT; see Table 1) and found that the PPV of the WT1 ratio of 20 improved to 69.2% in the high-risk patients (Table 3) compared to 58.3% for the entire cohort (Table 2).
By analyzing top 100 scoring PrDs of the viruses with the greatest prion-forming potential, we evaluated the highest LLR scores predominantly among Megavirales, Herpesviridae, and in viruses of unassigned orders (Supplementary Table 6).
Among the treatments evaluated, the highest production of dry biomass, with both maltose and sucrose, was observed for Mg (1.60 g/L and 1.94 g/L, respectively).
Among the structures evaluated, the highest affinity and potency in all series were exhibited by compounds containing 4-hydroxy and/or 2-chloro or 2-fluoro substituents.
Here, we evaluated the high-peptide density AuNVs through three steps: synthesis and characterization, AuNV uptake by dendritic cells, and functional in vitro immunologic assays.
We evaluated the highest value reached by a variable from the beginning of mechanical ventilation, that is D1, till D6 in VAP patients and non-infected controls.
We evaluated the high-throughput GST-L1, which is increasingly used in epidemiologic research, as a measure of cumulative HPV infection and future immune protection among HPV-unvaccinated women.
JG and HW performed biostatistical analyses, DAH, MK, AG, and EE evaluated the high-risk smokers and AG assisted in drafting the manuscript; DN provided the radiology readings of the CT-scans; BC examined the lung cancer patients, and ET and DL performed the autoantibody assays.
We also evaluated the highest grade of toxicity for each patient during the treatment course, in order to find during which time period of therapy we would expect the highest grade of toxicity.
